The Hospital for Endocrine Surgery, the world's leading destination for thyroid, parathyroid, and adrenal surgery, proudly ...

Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...

Personalized vaccine targets key driver mutations and induces antitumor immunity in fully resected high-risk clear cell renal cell carcinoma.

More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

Data on enfortumab vedotin plus pembrolizumab for advanced bladder cancer, along with updates on antibody-drug conjugates, biomarkers, and other cancer treatments, will be highlighted at the American ...

AI-driven deep learning models surpass expert radiologists in diagnosing kidney tumors using CT scans. The study highlights ...